Earnings release
Page 1
EX - 99.1 2 ex991 - q3dec2021 earningsrel.htm EX - 99.1 HAEMONETICS® Exhibit 99.1 Investor Contact Olga Guyette , Director - Investor Relations ( 781 ) 356-9763 olga.guyette@haemonetics.com Media Contact Carla Burigatto , VP - Communications ( 781 ) 348-7263 carla.burigatto@haemonetics.com Haemonetics Reports Third Quarter and Year - to - Date Fiscal 2021 Results Boston , MA , February 2 , 2021 - Haemonetics Corporation ( NYSE : HAE ) reported financial results for its third quarter and year - to - date fiscal 2021 , which ended December 26 , 2020 : In Revenue , decrease n Revenue decrease ( organic ) 1 n Earnings per diluted share 3rd Quarter 2021 $ 240 million , ( 7 % ) ( 6 % ) YTD 2021 $ 645 million , ( 14 % ) ( 12 % ) $ 0.62 $ 1.77 $ 0.81 $ 1.89 n Adjusted earnings per diluted share n Cash flow from operating activities n Free cash flow before restructuring & turnaround $ 66 million $ 61 million 1 Organic revenue excludes the impact of currency fluctuation , strategic exits of product lines , acquisitions and divestitures . $ 107 million $ 99 million Chris Simon , Haemonetics ' CEO , stated : “ In the third quarter , revenue improved sequentially and productivity from our Operational Excellence Program and cost management helped improve profitability . We are progressing with NexSysⓇ and TEGⓇ adoption and we are investing in our innovation agenda for future growth . The Cardiva Medical acquisition supports our strategy , diversifies our portfolio and is expected to create significant shareholder value . " GAAP RESULTS Third quarter fiscal 2021 revenue was $ 240.4 million , down 7.2 % compared with fiscal 2020 , primarily driven by the continued negative impact of COVID - 19 . Business unit revenue and growth rates compared with the prior year were as follows : ( $ millions ) Plasma Hospital Blood Center Net business unit revenue Service Total net revenue 3rd Quarter 2021 Reported $ 101.9 ( 15.4 % ) $ 52.7 4.7 % $ 80.9 ( 3.0 % ) $ 235.5 ( 7.3 % ) $ 4.9 ( 0.1 % ) $ 240.4 ( 7.2 % ) Gross margin was 50.0 % in the third quarter of fiscal 2021 , up 60 basis points compared with fiscal 2020. Operating expenses were $ 79.8 million in the third quarter of fiscal 2021 compared 1